
Journal of Medicinal Chemistry p. 1272 - 1276 (1989)
Update date:2022-07-29
Topics:
Dodd
Ouannes
Robert-Gero
Potier
The thiosemicarbazones of β-carboline-3-carboxaldehyde (compound 2) and 3-acetyl-β-carboline (compound 3) were found to effectively inhibit the in vitro growth of the promastigote form of Leishmania donovani, 50% inhibition being obtained at concentrations of 5.0 and 2.5 μM, respectively, while irreversible growth inhibition was achieved at 40 (compound 2) and 17.5 μM (compound 3). The thiosemicarbazone of pyridine-2-carboxaldehyde (compound 4) was considerably less active while both methyl β-carboline-3-carboxylate (compound 1) and the thiosemicarbazone of ethyl 5-formyl-6-azaindole-2-carboxylate (compound 5) were inactive at the highest concentrations tested. At concentrations provoking approximately 50% growth inhibition of promastigotes, compound 2 was observed to preferentially block DNA rather than RNA synthesis, but for compound 3, the reverse was true. Compound 3, the most active analogue studied, may thus act, at least partly, via a novel, though as yet unelucidated, mechanism.
View MoreHubei Lingsheng Pharmaceuticals Co., Ltd.
Contact:+86-0710-3538058
Address:Xiangyang City Xiangcheng Economic Development Zone, Hubei Province
Suzhou Howsine Biological Technology Co.,Ltd(expird)
website:http://www.howsine.com
Contact:86-512-67262751
Address:No 3,Weihua Road ,Suzhou Industrial Park ,Jiangsu ,China.
Weifang Ocean Trading Co., Ltd.
Contact:+86-536-2081155
Address:Room2606, Yuqing Building, 518#, Yuquan Road, High-tech Development Zone, Weifang City, Shandong Province, China
Suzhou Credit International Trading Co., Ltd
Contact:+86-512-65398039
Address:Qingdeng, Hightech. District, Suzhou
Suzhou Kangrun Pharmaceutical, Inc
Contact:86-512-63912376,63913329
Address:Building 2, No. 2358 ,Chang'an Rd, Wujiang Economic Development Zone Pioneering park, china
Doi:10.1021/om00107a003
(1989)Doi:10.1021/ja01557a027
(1958)Doi:10.1271/bbb.90218
(2009)Doi:10.1016/j.tet.2009.09.009
(2009)Doi:10.2478/s11532-013-0391-4
(2014)Doi:10.1055/s-0035-1560931
(2015)